Jaguar Health Inc. has released a corporate presentation providing an overview of its current financial status and business operations. The presentation highlights potential risks, including limitations on cash transfers between Sigma and its subsidiaries, reliance on consultants for mineral exploration, and impacts of the COVID-19 pandemic on its business. It also addresses challenges related to currency fluctuations, potential litigation, and conflicts of interest among its directors and officers. Furthermore, the presentation discusses the volatility of Sigma's share price and the company's need for future financing to maintain operations. You can access the full presentation through the link below.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.